Please login to the form below

Not currently logged in
Email:
Password:

Amitiza

This page shows the latest Amitiza news and features for those working in and with pharma, biotech and healthcare.

Lilly’s Efient and Sucampo's Amitiza win NICE backing

Lilly’s Efient and Sucampo's Amitiza win NICE backing

Lilly’ s Efient and Sucampo's Amitiza win NICE backing. Blood clot and constipation drugs recommended for NHS use. ... The Amitiza recommendation follows earlier draft guidance published in June that determined the drug was a cost effective treatment

Latest news

  • NICE backs constipation treatment NICE backs constipation treatment

    NICE backs constipation treatment. Sucampo’ s Amitiza set for NHS use in England and Wales. ... Sucampo's constipation treatment Amitiza (lubiprostone) should be available on the NHS, according to new healthcare guidance.

  • NICE backs constipation treatment NICE backs constipation treatment

    NICE backs constipation treatment. Sucampo’ s Amitiza set for NHS use in England and Wales. ... Sucampo's constipation treatment Amitiza (lubiprostone) should be available on the NHS, according to new healthcare guidance.

  • AZ drug for opioid constipation starts FDA review AZ drug for opioid constipation starts FDA review

    AZ drug for opioid constipation starts FDA review. Naloxegol on course to compete with Takeda’ s Amitiza. ... Sucampo reported Amitiza sales of a little over $80m in 2012 but that product is also tipped to reach $200m.

  • Sucampo-Takeda to file for US approval of Amitiza as OBD treatment

    It is estimated that 4.5m patients in the US suffer from OBD, so extending Amitiza's indications to include this use could dramatically increase sales. ... added. Sucampo is in the final stages of an arbitration process seeking to revise the terms of its

  • An unexpected turn

    Amitiza (Takeda Pharmaceuticals). Irritable Bowel Syndrome. US. Mycophenolate mofetil (Cellcept; Roche) is an immunosupressant commonly used for treating and preventing transplant rejection.

More from news
Approximately 3 fully matching, plus 6 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Fishawack Group of Companies

The Fishawack Group of Companies is one of the largest independent medical communications and medical marketing specialists, with teams in...

Latest intelligence

World Diabetes Day: Interaction and impact of diabetes on mental health
For World Diabetes Day on the 14th November 2018, Nisha Shahrukh - Medical Writer at Mednet Group has written an article depicting the impact diabetes has on mental health. Including...
EU
Innovation in merger control and the impact on the pharmaceutical sector
Is focusing on pipeline products enough to assess regulatory risks?...
Nudge-nudge, think-think
Chris Ross examines the personal complexities of human behaviour – and explains why fun, emotion and peer endorsement could be key to designing effective behavioural change programmes...

Infographics